Canopy Growth Corp vs NEOS S&P 500 High Income ETF — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while NEOS S&P 500 High Income ETF trades at $54.2. The key difference: NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | SPYI | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.92 | $54.19 |
52-Week Low | $0.86 | $47.98 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
SPYI trades at $54.19 with a flat 24-hour change, supported by a bullish technical signal from moving averages. The ETF focuses on generating high income through an options overlay on the S&P 500, with recent dividends around $0.53-$0.54 per share. News highlights its 11.7% yield appeal for retirement income, though some articles caution about fee gaps and yield sustainability.
The outlook hinges on volatility-driven income generation, offering tax-efficient distributions but facing risks from declining market volatility and potential principal erosion. Investors are drawn to the high yield for retirement cash flow, yet must weigh the trade-off between income and long-term capital appreciation in a competitive covered call ETF space.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →